http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1114714-T1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6db69aceffbde65c4c59633d9bb06036 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate | 2013-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f413b04eca7d4e9b89c4e89098fce029 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f74bbb402c2ef74262ec38629e474bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c25257ab90a70715ec75dd0934e57b65 |
| publicationDate | 2016-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CY-1114714-T1 |
| titleOfInvention | USE OF DIFFERIPRON AND METHODS FOR THE TREATMENT AND / OR PREVENTION OF FRIEDREICH DISTRIBUTION Caused by Intracellular Iron Management |
| abstract | A therapeutically effective amount of deferiprone or deferasirox or physiologically acceptable salts thereof for the prevention, stabilization, treatment or reversal of iron-induced FRDA disease in patients resulting from damage caused by iron mitochondria to reduced iron. Also for the treatment of other conditions affecting the brain where the key element in the creation of the resulting pathology is intracellular iron mismanagement. |
| priorityDate | 2006-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.